A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/506 (2006.01) A61P 9/12 (2006.01)
Patent
CA 2732789
The present invention pertains to the use of 4-(4-methylpiperazin-1-ylmethyl)- N-[4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino)phenyl]-benzamide or a pharmaceutically acceptable salt thereof or a pyrimidylaminobenzamide of formula I wherein the radicals and symbols are as defined herein, or a pharmaceutically acceptable salt thereof, for the manufacture of medicament for treating pulmonary arterial hypertension (PAH), especially in patients who failed prior PAH therapy.
La présente invention concerne lutilisation du 4-(4-méthylpipérazin-1-yl-méthyl)-N-[4-méthyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phényl]-benzamide ou de lun de ses sels pharmaceutiquement acceptables ou dun pyrimidylaminobenzamide de formule I dans laquelle les radicaux et les symboles sont tels que définis dans ce document, ou de lun de ses sels pharmaceutiquement acceptables, pour la fabrication dun médicament destiné au traitement de lhypertension artérielle pulmonaire (HAP), spécialement chez les patients pour lesquels un traitement antérieur de la HAP a échoué.
Pascoe Steve
Quinn Deborah
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Treatment of pulmonary arterial hypertension does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of pulmonary arterial hypertension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of pulmonary arterial hypertension will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1444352